BRAF and neoplasm: These diagnostic assays are necessary not only to determine the histologic characteristics of the tumor but also to select a treatment regimen, taking into account the possibility of targeted therapy with BRAF inhibitors, checkpoint inhibitors (immunotherapy), etc. [4,5].